Publicação

Mesalazine induced tubulointersticial nephritis

Ver documento

Detalhes bibliográficos
Resumo:Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Tubulointersticial nephritis is a rare but serious complication of longer-term mesalazine use. There are few cases reported in the literature. We report the first two cases of mesalazine-induced tubulointersticial nephritis, recently diagnosed in our department. The first one refers to a patient with ulcerous colitis and the second one to a patient with Crohn’s disease. Then the authors present a review of literature about the renal involvement in the inflammatory bowel disease. New cases of mesalazine nephrotoxicity should be reported to allow more accurate incidence estimation of this serious adverse effect. Routine monitoring of renal function is simple, inexpensive and allows an early diagnosis of this complication
Autores principais:Campos,Andreia
Outros Autores:Santos,Sofia; Santos,Josefina; Malheiro,Jorge; Rodrigues,Anabela; Lobato,Luísa; Viscaíno,J. Ramón; Cabrita,António
Assunto:Inflammatory bowel disease kidney disease mesalazine tubulointersticial nephritis
Ano:2015
País:Portugal
Tipo de documento:artigo
Tipo de acesso:acesso aberto
Instituição associada:Fundação para a Ciência e Tecnologia
Idioma:inglês
Origem:SciELO Portugal
Descrição
Resumo:Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Tubulointersticial nephritis is a rare but serious complication of longer-term mesalazine use. There are few cases reported in the literature. We report the first two cases of mesalazine-induced tubulointersticial nephritis, recently diagnosed in our department. The first one refers to a patient with ulcerous colitis and the second one to a patient with Crohn’s disease. Then the authors present a review of literature about the renal involvement in the inflammatory bowel disease. New cases of mesalazine nephrotoxicity should be reported to allow more accurate incidence estimation of this serious adverse effect. Routine monitoring of renal function is simple, inexpensive and allows an early diagnosis of this complication